ArticleBMJ open2023

Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia.

Vicki S Barber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.